MYC, a transcription factor frequently deregulated in cancers, increases the expression of SSP and mitochondrial 1C metabolism related enzymes, alone or in collaboration with other transcription factors such as activating transcription factor 4 (ATF4) or hypoxia-inducible factor1α (HIF1α)69–72. Here, ATF4 is linked to cancer.